Optometrists in Kerrville, TX Accepting Medicare

16 Optometrists found. Showing 1 - 16

Vision Optics Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1305 Sidney Baker St Ste B, Kerrville, TX 78028 Phone: 830-792-5880    Fax: 830-792-4950

Dr. Brandon Blaker, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 205-b West Water St., Kerrville, TX 78028 Phone: 830-896-4044    Fax: 830-257-6419

Heather Anderegg, O. D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1001 Water St Ste E-100, Kerrville, TX 78028 Phone: 830-257-4417    Fax: 830-257-1480

Bret B Ford, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 714 Hill Country Drive, Kerrville, TX 78028 Phone: 830-315-3673    Fax: 830-315-3939

Dr. Jeffrey Kevin Elkins, O.D. Optometrist - Corneal and Contact Management Medicare: Accepting Medicare Assignments Practice Location: 1216 Junction Hwy, Kerrville, TX 78028 Phone: 830-895-7858    Fax: 830-895-0003

Hill Country Vision Center Optometrist Medicare: Medicare Enrolled Practice Location: 205b W Water St, Kerrville, TX 78028 Phone: 830-896-2600

Vision Source Optometrist Medicare: Medicare Enrolled Practice Location: 708 Hill Country Dr, Suite 100, Kerrville, TX 78028 Phone: 830-257-5656    Fax: 830-257-5856

Aeg Texas Professional Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 205b W Water St, Kerrville, TX 78028 Phone: 830-896-2600

Dr. Benito Pena, O.D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 237 W Water St, Kerrville, TX 78028 Phone: 830-257-6336

Hiten Patel Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1810 Sidney Baker St, Kerrville, TX 78028 Phone: 210-316-2536

Dr. Stanley Martin Kremp, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 500 Junction Hwy, Kerrville, TX 78028 Phone: 830-257-6336    Fax: 830-792-4808

Ford Eye Care Center Optometrist Medicare: Medicare Enrolled Practice Location: 714 Hill Country Drive, Kerrville, TX 78028 Phone: 830-315-3673    Fax: 830-315-3939

Layne Mari Ford, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 714 Hill Country Dr, Kerrville, TX 78028 Phone: 308-315-3673    Fax: 830-315-3939

Texas State Optical Kerrville Optometrist Medicare: Medicare Enrolled Practice Location: 500 Junction Hwy, Kerrville, TX 78028 Phone: 830-257-6336    Fax: 830-792-4808

Peter J Rothermel, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 205 B West Water, Kerrville, TX 78028 Phone: 830-792-5880

Phillip Andrew Whitehead, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 708 Hill Country Dr Ste 100, Kerrville, TX 78028 Phone: 830-257-5656

News Archive

Roche, Isis Pharmaceuticals to develop neurodegenerative therapeutics for Huntington's disease

Roche and Isis Pharmaceuticals, Inc today announced that they have formed an alliance to develop treatments for Huntington's disease based on Isis' antisense oligonucleotide technology.

Timing of food consumption affects circadian rhythms and body weight

A new high-precision feeding system for lab mice reinforces the idea that the time of day food is eaten is more critical to weight loss than the amount of calories ingested.

Investigators report complete catalog of genes expressed in retina

Investigators at Massachusetts Eye and Ear and Harvard Medical School have published the most thorough description of gene expression in the human retina reported to date. In a study published today in the journal BMC Genomics, Drs. Michael Farkas, Eric Pierce and colleagues in the Ocular Genomics Institute at Mass. Eye and Ear reported a complete catalog of the genes expressed in the retina.

FDA provides a Complete Response Letter for Somaxon Pharmaceuticals' Silenor NDA

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that the company has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.

Read more Medical News

› Verified 1 days ago